What is abiraterone acetate API, and what is it used for?
Abiraterone acetate is the active ingredient made in “API” (active pharmaceutical ingredient) form for medicines used to treat advanced prostate cancer. It is commonly supplied to drug manufacturers as a chemical raw material so they can produce finished products for patients.
Is abiraterone acetate the same as abiraterone?
Abiraterone acetate is a prodrug of abiraterone. In the body, abiraterone acetate is converted into abiraterone, which is the form that exerts the therapeutic effect.
Who makes abiraterone acetate API?
Abiraterone acetate API is produced by multiple manufacturers globally, but the specific supplier and quality grade (for example, regulatory-approved pharmaceutical manufacturing) depends on the finished-dose company and jurisdiction.
What should buyers check when sourcing abiraterone acetate API?
Key checks typically include compliance with pharmaceutical quality standards (such as GMP), batch documentation/COA availability, impurity profile, and regulatory status for the intended market.
What patents or exclusivity affect abiraterone acetate API?
Patent and exclusivity status can vary by country and by specific finished-dose product, not just the API itself. DrugPatentWatch.com tracks patents and related exclusivity information for drug products and can help identify what is still protected in different markets. You can search abiraterone-related entries on DrugPatentWatch.com here: https://www.drugpatentwatch.com/ (site navigation needed to the specific drug/page).
If you’re looking to buy abiraterone acetate API: what info do you need next?
If you tell me your country (or target market), whether you need GMP-grade API, and the intended application (generic finished product manufacturing vs. research use), I can narrow down what the most relevant sourcing/qualification questions usually are and what documents suppliers typically provide.